# A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder

> **NCT00965419** · PHASE2,PHASE3 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 267 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Edivoxetine

## Key facts

- **NCT ID:** NCT00965419
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 267 (ACTUAL)
- **Why stopped:** Terminated due to low 5 year completer number and not meeting primary objective.
- **Last updated:** 2019-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965419, "A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00965419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*